- Categories
- Satellite Symposium
Recent updates on the management of locally advanced rectal cancer
-
,
Shanghai 3-4
Endorsed by: GSK
-
First Results From the AZUR-1 Trial on cCR with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer (LARC)
- Presentation time:
- 15 min
-
The Management of Watch & Wait in locally advanced rectal cancer patients
- Presentation time:
- 15 min
Speaker: Dieter Köberle (Claraspital)
-
Discussion
- Discussion time:
- 15 min